Second edition

06.qxd 3/10/08 9:34 AM Page 231
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous
system events associated with dietary supplements containing
ephedra alakaloids. N Engl J Med 2000; 343:1833–8.
Han CS, Kim YK. A double-blind trial of risperidone and
haloperidol for the treatment of delirium. Psychosomatics
2004; 45:297–301.
Hantz P, Caradoc-Davies G, Caradoc-Davies T et al. Depression in
Parkinson’s disease. Am J Psychiatry 1994; 151:1010–14.
Hardwick SW. Pellagra in psychiatric patients: twelve recent
cases. Lancet 1943; 2:43–5.
Harlow SD, Goldberg EL, Constock GW. A longitudinal study of the
prevalence of depressive symptomatology in elderly widowed
and married women. Arch Gen Psychiatry 1991; 48:1065–8.
Haskett RF. Diagnostic categorization of psychiatric disturbance
in Cushing’s syndrome. Am J Psychiatry 1985; 142:911–16.
Heathfield KW. Huntington’s chorea. Investigation into the
prevalence of the disease in the area covered by the North
East Metropolitan Regional Hospital Board. Brain 1967;
90:203–32.
Hermann M, Bartels C, Wallesch C-W. Depression in acute and
chronic aphasia: symptoms, pathoanatomical–clinical
correlations and functional implications. J Neurol Neurosurg
Psychiatry 1993; 56:672–8.
Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in
patients on fluvoxamine and fluoxetine. J Clin
Psychopharmacol 1990; 10:343–5.
Hohman LB. Epidemic encephalitis (lethargic encephalitis): its
psychotic manifestations with a report of twenty-three cases.
Arch Gen Psychiatry 1921; 6:295–333.
Holland JC, Korzun AH, Tross S et al. Comparative psychological
disturbance in patients with pancreatic and gastric cancer. Am
J Psychiatry 1986; 143:982–6.
House A, Dennis M, Warlow C et al. Mood disorders after stroke
and their relation to lesion location. Brain 1990; 1113–29.
Hughes JR, Hatsukami D. Signs and symptoms of tobacco
withdrawal. Arch Gen Psychiatry 1986; 43:289–94.
Hughes JR, Higgins ST, Bickel WK et al. Caffeine self-administration,
withdrawal, and adverse effects among coffee drinkers. Arch
Gen Psychiatry 1991a; 48:611–17.
Hughes JR, Gust SW, Skoog K et al. Symptoms of tobacco
withdrawal: a replication and extension. Arch Gen Psychiatry
1991b; 48:52–9.
Hugo FJ, Halland AM, Spangenberg JJ et al. DSM-III-R
classification of psychiatric symptoms in systemic lupus
erythematosus. Psychosomatics 1996; 37:262–9.
Hullett FJ, Potkin SG, Levy AB et al. Depression associated with
nifedipine-induced calcium channel blockade. Am J Psychiatry
1988; 145:1277–9.
Indaco A, Carrieri PB, Nappi C et al. Interictal depression in
epilepsy. Epilepsy Res 1992; 12:45–50.
Ingham SD, Nielsen JM. Thyroid psychosis: difficulties in
diagnosis. J Nerv Ment Dis 1931; 74:271–7.
Ironside R, Guttmacher M. The corpus callosum and its tumors.
Brain 1929; 52:442–83.
Isbell H, Fraser HF, Wickler A et al. An experimental study of
etiology of ‘rum fits’ and delirium tremens. Q J Stud Alcohol
1955; 16:1–33.
References 231
Isbell H, Belleville RE, Fraser HF et al. Studies on lysergic acid
diethylamide (LSD–25). Arch Neurol Psychiatry 1956;
76:468–78.
Isella V, Melzi P, Grimaldi M et al. Clinical, neuropsychological,
and morphometric correlates of apathy in Parkinson’s disease.
Mov Disord 2002; 17:366–71.
Jack RA. A case of mania secondary to propafenone. J Clin
Psychiatry 1985; 46:104–5.
Jack RA, Rivers-Bulkeley NT, Rabin PL. Single case study:
secondary mania as a presentation of progressive dialysis
encephalopathy. J Nerv Ment Dis 1983; 171:193–5.
Jackson SL. Psychosis due to isoniazid. Br Med J 1957; 2:743–6.
Jampala VC, Taylor MA, Abrams R. The diagnostic implications of
formal thought disorder in mania and schizophrenia: a
reassessment. Am J Psychiatry 1989; 146:459–63.
Jensen K. Depression in patients treated with reserpine for arterial
hypertension. Acta Psychiatr Neurol Scand 1959; 34:195–204.
Jimenez-Jimenez FJ, Tejeiro J, Martinez-Junquera G et al.
Parkinsonism exacerbated by paroxetine. Neurology 1994;
44:2406.
Jochum T, Bar KJ, Sauer H. Topiramate-induced manic episode. J
Neurol Neurosurg Psychiatry 2002; 73:208–10.
Johnson RJ, Richardson EP. The neurological manifestations of
systemic lupus erythematosus. Medicine 1968; 47:337–69.
Jones AM. Psychiatric presentation of a third ventricular colloid
cyst in a mentally handicapped woman. Br J Psychiatry 1993;
163:677–8.
Jorge RE, Robinson RG, Starkstein SE et al. Secondary mania
following traumatic brain injury. Am J Psychiatry 1993a;
150:916–21.
Jorge RE, Robinson RG, Starkstein SE et al. Depression and anxiety
following traumatic brain injury. J Neuropsychiatry Clin
Neurosci 1993b; 5:369–74.
Kahana E, Liebowitz U, Alter M. Cerebral multiple sclerosis.
Neurology 1971; 21:1179–85.
Kant R, Smith-Seemiller L, Zeiler D. Treatment of aggression and
irritability after head injury. Brain Inj 1998; 12:661–6.
Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to
methylphenidate. J Am Geriatr Soc 1975; 23:271–6.
Karpati G, Frame B. Neuropsychiatric disorders in primary
hyperparathyroidism. Arch Neurol 1964; 10:387–97.
Kathol RG, Delahunt JW. The relationship of anxiety and
depression to symptoms of hyperthyroidism using operational
criteria. Gen Hosp Psychiatry 1986; 8:23–8.
Kelly WF. Psychiatric aspects of Cushing’s syndrome. Q J Med
1996; 89:543–51.
Kent TA, Wilber RD. Single case study: reserpine withdrawal
psychosis: the possible role of denervation supersensitivity of
receptors. J Nerv Ment Dis 1982; 170:502–4.
Khanna R, Borde M. Mania in a five-year-old child with tuberous
sclerosis. Br J Psychiatry 1989; 155:117–19.
Kim E, Bijlani M. A pilot study of quetiapine treatment of
aggression due to traumatic brain injury. J Neuropsychiatry
Clin Neurosci 2006; 18:547–9.
Kirubakaren V, Mayfield D, Rengachary S. Dyskinesia and
psychosis in a patient following baclofen withdrawal. Am J
Psychiatry 1984; 141:692–3.